STING1 and hepatocellular carcinoma: Collectively, this nanoplatform with dual‐mediated cellular pyroptosis and STING pathway can effectively remodel the immunosuppressive HCC microenvironment associated with iMWA and significantly inhibit HCC cell activity, which lays a solid foundation for reducing the risk of recurrence in patients with non‐radical treatment.